Search | Clinical Trials Finder

Conditions: Healthy
Interventions: Natural Compound A (Hinoki essential oil), Natural Compound B (Lemon essential oil), Natural Compound C (Control/Water); Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Fibromyalgia, Healthy Volunteers
Interventions: EEG, Neuroimaging EEG/fMRI (Aim 1), HD-tDCS treatments, Sham HD-tDCS treatments, Neuroimaging EEG/fMRI (Aim 3); Diagnostic Test · Device
Lead sponsor: University of Michigan; Other
Eligibility: 19 Years to 74 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Growth Disorders, Insulin-Like Growth Factor-1 Deficiency
Interventions: rhIGF-1 (mecasermin, Tercica, Inc.); Drug
Lead sponsor: Ipsen; Industry
Eligibility: 3 Years to 12 Years
Enrollment: 137 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Brisbane, California

Conditions: Bronchiolitis Obliterans Syndrome (BOS)
Interventions: Extracorporeal Photopheresis (ECP), No intervention in the SOC / Retrospective Chart review.; Combination Product · Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 280 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2028
U.S. locations: 22
States / cities: Birmingham, Alabama • Phoenix, Arizona • La Jolla, California + 18 more

Conditions: Urinary Tract Infections
Interventions: D-Mannose; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 20 Years and older · Female only
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Child Obesity
Interventions: Child Safety Control Intervention, Responsive Parenting Intervention; Behavioral
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: Not listed
Enrollment: 216 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 2
States / cities: Hershey, Pennsylvania • State College, Pennsylvania

Conditions: Traumatic Brain Injury, Venous Thromboembolism
Interventions: Observational, Observational-control; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 15,000 participants
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Ischemia, Peripheral Arterial Disease, Peripheral Vascular Disease, Vascular Disease, Arterial Occlusive Disease, Arteriosclerosis, Atherosclerosis, Cardiovascular Disease, Pathologic Processes, Orthopedic Procedures, Amputation
Interventions: Allogeneic bone marrow derived mesenchymal stem cells; Biological
Lead sponsor: Indiana University; Other
Eligibility: 40 Years to 90 Years
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Stress, Anxiety, Depression
Interventions: VR Mindfulness Meditation Program; Behavioral
Lead sponsor: Penn State University; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Erie, Pennsylvania

Conditions: Sequelae of Viral Hepatitis, Transplantation Infection, Evidence of Liver Transplantation
Interventions: Hepatitis C Immune Globulin Intravenous (Human) 5%; Biological
Lead sponsor: ADMA Biologics, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 3
States / cities: Phoenix, Arizona • Jacksonville, Florida • Rochester, Minnesota

Conditions: Hemianopia, Homonymous
Interventions: Biofeedback Fixation Training, Saccadic Reading Training; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 89 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Smoking, Diabetes
Interventions: Dental implant surgery; Procedure
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 70 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Stroke, Hemiparesis
Interventions: Action Observation + Repetitive Task Practice, Placebo Video + Repetitive Task Practice; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Spinal Muscular Atrophy Type 3, Duchenne Muscular Dystrophy
Interventions: Observational; Other
Lead sponsor: Columbia University; Other
Eligibility: 5 Years and older
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Metastatic Malignant Neoplasm to Brain, Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Hypofractionated Radiosurgery; Radiation
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2023
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Anosognosia, Alzheimer's Disease, Mild Cognitive Impairment
Interventions: Not listed
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 60 Years to 90 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Very Low Birth Weight Infant
Interventions: cord milking; Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: Up to 32 Weeks
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Aneurysmal Subarachnoid Hemorrhage, Cerebral Vasospasm
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Depression, End Stage Renal Disease
Interventions: Engagement Interview, Cognitive Behavioral Therapy, Antidepressant Drug Therapy; Behavioral · Drug
Lead sponsor: University of Washington; Other
Eligibility: 21 Years and older
Enrollment: 184 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 3
States / cities: Albuquerque, New Mexico • Dallas, Texas • Seattle, Washington

Conditions: Psoriasis Vulgaris
Interventions: Not listed
Lead sponsor: LEO Pharma; Industry
Eligibility: 18 Years and older
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 12
States / cities: Phoenix, Arizona • Fremont, California • Clearwater, Florida + 9 more

Conditions: Amyotrophic Lateral Sclerosis (ALS), Motor Neuron Disease (MND), Primary Lateral Sclerosis (PLS)
Interventions: Education about treatment options, Dietary Supplements: Vitamins, Minerals, Herbs, etc., Meditation, Prayer, Talk Therapy, Affirmations, Journaling, etc., Diet, various diets will be observed, Exercise, physical therapy, occupational therapy, speech therapy, sauna, EMS, massage and other therapies, ALS medications and other medications, Physical and emotional support; Other · Dietary Supplement · Behavioral + 1 more
Lead sponsor: Healing Advocates Registry and Ministry; Other
Eligibility: 18 Years to 110 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2036
U.S. locations: 1
States / cities: Park City, Utah

Conditions: Epidermolysis Bullosa, Epidermolysis Bullosa Acquisita, Dystrophic Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa
Interventions: Immunoglobulin G; Biological
Lead sponsor: M. Peter Marinkovich; Other
Eligibility: 6 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Redwood City, California

Conditions: Pulmonary Arterial Hypertension
Interventions: inhaled prostacyclin, prostacyclin, subcutaneous and intravenous prostacyclin, oral ERA, oral PDE5 inhibitors; Drug
Lead sponsor: United Therapeutics; Industry
Eligibility: Not listed
Enrollment: 1,333 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 88
States / cities: Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 65 more

Conditions: Limbal Stem Cell Deficiency
Interventions: CSB-001 Ophthalmic Solution 0.1%; Biological
Lead sponsor: Claris Biotherapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 6
States / cities: Loma Linda, California • Carmel, Indiana • Indianapolis, Indiana + 3 more

Search by objective public record fields.

Beneficial Exposome Study

Explosive Synchronization of Brain Network Activity in Chronic Pain

Prepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) Deficiency

Extracorporeal Photopheresis for Medicare Recipients of Lung Allografts

Nutraceutical Efficacy for rUTI

Intervention Nurses Start Infants Growing on Healthy Trajectories (INSIGHT) - Long Term Follow-Up

Evaluation of the SCALED (SCaling AcceptabLE cDs)

A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation

Assessing the Impact of VR-Based Observational Mindfulness Meditation on Stress Reduction in Adults

Randomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplantation

Comparative Efficacy of Saccadic and Biofeedback Training in Homonymous Hemianopia

Gene Expression Variation and Implant Wound Healing Among Smokers and Diabetics

Feasibility of Action Observation and Repetitive Task Practice on Upper Extremity Outcomes in Chronic Stroke Survivors

Wearable Technology to Assess Gait Function in SMA and DMD

Hypofractionated Stereotactic Radiosurgery in Treating Patients With Large Brain Metastasis

Functional Magnetic Resonance Imaging (fMRI) of Anosognosia in Amnestic Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)

Cord Milking Impacts Neurodevelopmental Outcomes in Very Low Birth Weight Infants

Nitric Oxide Consumption as a Predictor of Vasospasm in Subarachnoid Hemorrhage

A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}

An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of Life

Healing ALS Registry Observational Study (HAROS)

Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa

Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies

Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency